Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

VLA-4/CD49d downregulated on primed T lymphocytes during interferon-beta therapy in multiple sclerosis.
Treatment Options to Reduce Disease Activity After Natalizumab: Paradoxical Effects of Corticosteroids.
Safety and tolerability of daclizumab HYP treatment in relapsing-remitting multiple sclerosis: results of the DECIDE study
Ampyra (Fampyra)
Reduction of CD8(+) T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate.
Quantifying brain volumes for Multiple Sclerosis patients follow-up in clinical practice - comparison of 1.5 and 3 Tesla magnetic resonance imaging.
Dimethyl fumarate (BG-12, Tecfidera) approved for use by the NHS in Scotland
Antibodies to Interferon beta in Patients with Multiple Sclerosis Receiving CinnoVex, Rebif, and Betaferon.
Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy.
Mechanism of action for leflunomide in rheumatoid arthritis.
The budget impact of introducing delayed-release dimethyl fumarate for treatment of relapse-remitting multiple sclerosis in Canada.
How integrated are neurology and palliative care services? Results of a multicentre mapping exercise.
Synergistic Effects of Reserve and Adaptive Personality in Multiple Sclerosis.
'Clinically definite benign multiple sclerosis', an unwarranted conceptual hodgepodge: evidence from a 30-year observational study.
Cognitive Impairment in Multiple Sclerosis: Clinical Manifestation, Neuroimaging Correlates, and Treatment.
CNS vasculitis in a patient with MS on daclizumab monotherapy.
Bioengineered cell culture systems of central nervous system injury and disease.
Monomethyl fumarate augments NK cell lysis of tumor cells through degranulation and the upregulation of NKp46 and CD107a.
Clinical proteomics of enervated neurons.
Interferon beta 1a anaphylaxis, a case report. Standardization of non-irritating concentration for allergy skin.
Polymorphism in Leptin and Leptin Receptor Genes May Modify Leptin Levels and Represent Risk Factors for Multiple Sclerosis.
Multiple sclerosis and chronic progressive external ophthalmoplegia associated with a large scale mitochondrial DNA single deletion.
Flupirtine as Oral Treatment in Multiple Sclerosis (FLORIMS)
Is No Evidence of Disease Activity a Realistic Goal for Patients With Multiple Sclerosis?
Optical coherence tomography and neurodegeneration: are eyes the windows to the brain?

Pages